NCT01380431View on ClinicalTrials.gov

A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

October 31, 1999

Study Completion Date

October 31, 1999

Conditions
To Determine Bioequivalence Under Fed Conditions
Interventions
DRUG

Lisinopril

Tablets, 40 mg, single oral dose

DRUG

lisinopril

Tablets, 40 mg, single, oral dose

DRUG

Lisinopril

50% of subjects received the Par formulated product.

Trial Locations (1)

21201

PharmaKinetics Laboratories, Inc., Baltimore

Sponsors
All Listed Sponsors
collaborator

PharmaKinetics Laboratories Inc.

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY